- Home
- AAMI vs AGL Comparison
AAMI vs AGL Comparison
Compare AAMI & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAMI
- AGL
- Stock Information
- Founded
- AAMI 1980
- AGL 2016
- Country
- AAMI United States
- AGL United States
- Employees
- AAMI N/A
- AGL N/A
- Industry
- AAMI Investment Managers
- AGL Managed Health Care
- Sector
- AAMI Finance
- AGL Health Care
- Exchange
- AAMI Nasdaq
- AGL Nasdaq
- Market Cap
- AAMI 1.1B
- AGL 894.1M
- IPO Year
- AAMI N/A
- AGL 2021
- Fundamental
- Price
- AAMI $35.80
- AGL $2.42
- Analyst Decision
- AAMI Hold
- AGL Hold
- Analyst Count
- AAMI 2
- AGL 20
- Target Price
- AAMI $27.00
- AGL $4.47
- AVG Volume (30 Days)
- AAMI 250.6K
- AGL 3.5M
- Earning Date
- AAMI 07-31-2025
- AGL 08-05-2025
- Dividend Yield
- AAMI 0.11%
- AGL N/A
- EPS Growth
- AAMI 46.05
- AGL N/A
- EPS
- AAMI 2.40
- AGL N/A
- Revenue
- AAMI $519,799,999.00
- AGL $5,988,958,000.00
- Revenue This Year
- AAMI $5.28
- AGL N/A
- Revenue Next Year
- AAMI $6.24
- AGL $10.12
- P/E Ratio
- AAMI $14.68
- AGL N/A
- Revenue Growth
- AAMI 18.00
- AGL 23.07
- 52 Week Low
- AAMI $21.49
- AGL $1.50
- 52 Week High
- AAMI $35.99
- AGL $7.73
- Technical
- Relative Strength Index (RSI)
- AAMI N/A
- AGL 45.91
- Support Level
- AAMI N/A
- AGL $2.06
- Resistance Level
- AAMI N/A
- AGL $2.42
- Average True Range (ATR)
- AAMI 0.00
- AGL 0.11
- MACD
- AAMI 0.00
- AGL 0.07
- Stochastic Oscillator
- AAMI 0.00
- AGL 63.64
About AAMI Acadian Asset Management Inc. Common Stock
Acadian Asset Management Inc is a holding company that operates a systematic investment management business through its subsidiary, that offers institutional investors across the globe access to a diversified array of systematic investment strategies designed to meet a range of risk and return objectives.
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.